Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- By Application
5.1 Introduction
5.2 Muscle Weakness
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Autoimmune Disorders
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other Applications
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Osteoporosis
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Rickets
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Skin Diseases
5.7.1 Market Overview
5.7.2 Market Size and Forecast
- By Age Group
6.1 Introduction
6.2 Adults
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Senior Adults
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Children
6.4.1 Market Overview
6.4.2 Market Size and Forecast
- By Purchasing Pattern
7.1 Introduction
7.2 Prescription Drugs
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 OTC Drugs
7.3.1 Market Overview
7.3.2 Market Size and Forecast
- By Route of Administration
8.1 Introduction
8.2 Parenteral Route
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Oral Route
8.3.1 Market Overview
8.3.2 Market Size and Forecast
- By Geography
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Application
9.2.2 Europe Market, By Age Group
9.2.3 Europe Market, By Purchasing Pattern
9.2.4 Europe Market, By Route of Administration
9.3 North America
9.3.1 North America Market, By Application
9.3.2 North America Market, By Age Group
9.3.3 North America Market, By Purchasing Pattern
9.3.4 North America Market, By Route of Administration
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Application
9.4.2 Asia Pacific Market, By Age Group
9.4.3 Asia Pacific Market, By Purchasing Pattern
9.4.4 Asia Pacific Market, By Route of Administration
9.5 Rest of The World
9.5.1 Rest of The World Market, By Application
9.5.2 Rest of The World Market, By Age Group
9.5.3 Rest of The World Market, By Purchasing Pattern
9.5.4 Rest of The World Market, By Route of Administration
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
11.1 Sanofi
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Torrent Pharmaceuticals Ltd.
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Sun Pharmaceutical Industries Ltd.
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Alkem Laboratories Ltd.
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Cadila Healthcare Ltd
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Novartis AG
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Pfizer Inc
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 GlaxoSmithKline PLC
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Merck & Co., Inc.
&